14
total announcements
533543.BO · 15 min delayed
Brooks Laboratories Ltd
Brooks Laboratories Ltd has published an addendum to the notice of its 24th Annual General Meeting, which was scheduled to be held on September 3, 2026. The addendum was published in the Financial Express and Jansatta newspapers on August 22, 2026. The company's registered office and works are located in Baddi, Himachal Pradesh.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has issued an addendum to the notice of its 24th Annual General Meeting, amending Resolution No. 4 and its explanatory statement regarding a corporate guarantee arrangement. The addendum is available on the company's website and will be considered for all future references.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has issued an addendum to the notice of its 24th Annual General Meeting, updating Resolution No. 4 and its explanatory statement regarding a corporate guarantee arrangement.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the record date, e-voting dates, and book closure date for its 24th Annual General Meeting. The book closure period will be from August 27, 2026, to September 3, 2026, and the e-voting period will be from August 31, 2026, to September 2, 2026.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has published unaudited financial results for the quarter ended 30th June 2026, as per Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 141.86 lakhs and a loss of Rs. 178.69 lakhs for the consolidated entity.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, showing a net profit of Rs. 141.86 lakhs and earnings per share of Rs. 0.48.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the publication of a notice in newspapers regarding the 24th Annual General Meeting (AGM) to be held on September 3, 2026, through video conference or other audio-visual means.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its Annual Report for the FY 2025-26 and scheduled its 24th Annual General Meeting (AGM) to be held on September 3, 2026. The company has also requested shareholders to update their KYC details and dematerialize physical securities.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the notice of its 24th Annual General Meeting (AGM) to be held on September 3, 2026, through video conferencing.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its 24th Annual General Meeting (AGM) for the financial year 2025-26, to be held on September 3, 2026, through video conferencing. The meeting will consider the adoption of audited standalone and consolidated financial statements, appointment of a director, and ratification of the remuneration of the cost auditors.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the intimation of its 24th Annual General Meeting to be held on September 3, 2026, through Video Conference (VC)/Other Audio-Visual Means (OAVM).
Brooks Laboratories Ltd
Brooks Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.
Brooks Laboratories Ltd
Brooks Laboratories Ltd announced the closure of its trading window for Designated Persons and their immediate relatives, effective from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. This is a standard compliance measure as per SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct, aimed at preventing insider trading.